Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Malignant Lymphoma

  Free Subscription


07.09.2026

1 Am J Clin Pathol
1 Am J Hematol
1 Am J Surg Pathol
3 Blood
1 BMC Cancer
1 Bone Marrow Transplant
5 Br J Haematol
1 Cancer
4 Eur J Haematol
2 J Am Acad Dermatol
1 J Natl Cancer Inst
2 Leuk Lymphoma


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. LOVE J, Verma T, Palmer P, Naresh KN, et al
    BRAF V600E-mutated marginal zone lymphoma may exhibit features that partially overlap with hairy cell leukemia.
    Am J Clin Pathol. 2026;166:aqag099.
    PubMed         Abstract available


    Am J Hematol

  2. ZHOU J, Wang C, You T, Wang Y, et al
    Real-World Efficacy and Safety of Glofitamab-Based Salvage Therapy in Chinese Patients With Relapsed or Refractory Aggressive B-Cell Lymphomas.
    Am J Hematol. 2026;101 Suppl 3:6-17.
    PubMed         Abstract available


    Am J Surg Pathol

  3. MURAMATSU A, Yamashita D, Tsuyuki Y, Satou A, et al
    Differential Expression of RORgammat and T-bet in ALK-Negative Anaplastic Large Cell Lymphoma: Implications for Biological Heterogeneity and Differential Diagnosis.
    Am J Surg Pathol. 2026 Sep 3. doi: 10.1097/PAS.0000000000002602.
    PubMed         Abstract available


    Blood

  4. KRUPKA JA, Pott C, Hodson DJ
    Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL).
    Blood. 2026 Sep 3:blood.2026033074. doi: 10.1182/blood.2026033074.
    PubMed         Abstract available

  5. NITHAGON P, Saksena A
    Classic Hodgkin lymphoma showing interfollicular and intrasinusoidal involvement.
    Blood. 2026;148:1364.
    PubMed        

  6. MAGNANO L, Lopez-Guillermo A, Maurer MJ
    A framework to challenge the dogma of incurability in follicular lymphoma.
    Blood. 2026 Sep 2:blood.2026035096. doi: 10.1182/blood.2026035096.
    PubMed         Abstract available


    BMC Cancer

  7. LIU S, Liu S, Hu Y, Deng J, et al
    Long-term cardiovascular risk in survivors of hematologic malignancies: a meta-analysis.
    BMC Cancer. 2026;26:1042.
    PubMed         Abstract available


    Bone Marrow Transplant

  8. SCHROEDER JC, Peczynski C, Berning P, Michel E, et al
    Pre-CAR-T B-cell-directed immunotherapy exposure and outcomes after CD19 CAR-T for large B-cell lymphoma: An EBMT registry analysis.
    Bone Marrow Transplant. 2026 Sep 1. doi: 10.1038/s41409-026-02979.
    PubMed        


    Br J Haematol

  9. PIROSA MC, Brodtkorb M, Schar S, Wahlin BE, et al
    SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma.
    Br J Haematol. 2026 Aug 30. doi: 10.1111/bjh.70801.
    PubMed         Abstract available

  10. GUIDEZ S, Belot A, Cherblanc F, Lesne B, et al
    Outcomes of refractory and early-relapsed large B-cell lymphoma patients after first-line treatment in the prospective Real-world dAta in LYmphoma patients and Survival in Adults (REALYSA) cohort in the pre-CAR T era.
    Br J Haematol. 2026 Aug 30. doi: 10.1111/bjh.70812.
    PubMed        

  11. AWAN FT, Liu R, Huang HH, Bye M, et al
    Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Br J Haematol. 2026 Aug 31. doi: 10.1111/bjh.70803.
    PubMed         Abstract available

  12. WANG J, Gao Y, Grant SM, Hwang SR, et al
    Improved overall survival in classical Hodgkin lymphoma across therapeutic eras: A National Cancer Database study.
    Br J Haematol. 2026 Sep 1. doi: 10.1111/bjh.70776.
    PubMed        

  13. MERLI M, Bianchi B, Bibas M, Dalu D, et al
    Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi.
    Br J Haematol. 2026 Sep 4. doi: 10.1111/bjh.70793.
    PubMed         Abstract available


    Cancer

  14. LAWRENCE L
    FDA grants accelerated approval to BCL-2 inhibitor sonrotoclax for mantle cell lymphoma.
    Cancer. 2026;132:e70537.
    PubMed        


    Eur J Haematol

  15. VEGLIANTE MC, Gargano G, Pappagallo SA, Minoia C, et al
    A Reassessment of the Validity of the Routine Lymph2Cx Assay for the Cell-of-Origin Assignment of Diffuse Large B-Cell Lymphoma.
    Eur J Haematol. 2026 Sep 3. doi: 10.1111/ejh.70305.
    PubMed         Abstract available

  16. ESKESEN MH, Fuglkjaer AD, El-Galaly TC, Jensen P, et al
    Risk Factors of Blood Culture Positivity and Mortality in Bloodstream Infections: A Population-Based Study of Patients With B-Cell Malignancies.
    Eur J Haematol. 2026;117:1061-1071.
    PubMed         Abstract available

  17. MA C, Lu Y, Li J, Liu W, et al
    Second Primary Malignancies in Patients With B-Cell Lymphomas Treated With Bruton's Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis.
    Eur J Haematol. 2026;117:1016-1025.
    PubMed         Abstract available

  18. SAINATHAM C, Goloubeva O, Margiotta P, Alharthy H, et al
    Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T Recipients.
    Eur J Haematol. 2026;117:936-942.
    PubMed         Abstract available


    J Am Acad Dermatol

  19. KENT JA, Sacknovitz Y, Fisch SA, Erem SA, et al
    Recent Incidence Trends for Cutaneous T-Cell Lymphoma in the United States: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis, 2000-2022.
    J Am Acad Dermatol. 2026 Sep 2:S0190-9622(26)03455.
    PubMed        

  20. KENT JA, Sacknovitz Y, Erem SA, Pro B, et al
    Concentration of Mechlorethamine Prescribing Among a Small Number of Specialists: Implications for Access to Cutaneous T-Cell Lymphoma Care.
    J Am Acad Dermatol. 2026 Sep 2:S0190-9622(26)03458.
    PubMed        


    J Natl Cancer Inst

  21. RAVINDRAN M, Peng J, Zipursky J, Luo J, et al
    Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.
    J Natl Cancer Inst. 2026 Sep 1:djag305. doi: 10.1093.
    PubMed         Abstract available


    Leuk Lymphoma

  22. FORSSTROM V, Itala-Remes M
    Allogeneic hematopoietic cell transplantation in Hodgkin lymphoma-single-center retrospective analysis.
    Leuk Lymphoma. 2026 Sep 3:1-3. doi: 10.1080/10428194.2026.2727811.
    PubMed        

  23. IBRAHIM RAE, Ahmed BA, Bahr AR, ElShazly M, et al
    Hypereosinophilic syndrome and suspected myeloid neoplasia in relapsed Hodgkin lymphoma during immune checkpoint inhibitor therapy: a rare case.
    Leuk Lymphoma. 2026 Aug 30:1-5. doi: 10.1080/10428194.2026.2725345.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum